The National Institutes of Health (NIH), specifically the National Institute of Child Health and Development (NICHD) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), intends to award a non-competitive purchase order to Metabolon, Inc. for Metabolomic Analysis Services. The procurement aims to utilize Metabolon's proprietary Global Discovery Panel for analyzing over 5000 metabolites in various biological samples, which is critical for research on the effects of microbiomes on host physiology and immune responses. This analysis will support ongoing studies related to liver diseases, with results expected within 16 weeks of sample receipt and a performance period of five months. Interested parties may submit capability statements by September 17, 2025, to be considered for this non-competitive procurement, with further inquiries directed to Jacob Balenson at jacob.balenson@nih.gov or 301-827-8302.